Immunogen, inc. reports first quarter fiscal year 2012 financial results and provides quarterly update
ImmunoGen, Inc., 10/28/2011
ImmunoGen, Inc. (Nasdaq:IMGN), a biotechnology company that develops targeted anticancer products using its antibody expertise and Targeted Antibody Payload (TAP) technology, today reported financial results for the three–month period ended September 2011 – the first quarter of the Company's 2012 fiscal year.



